Neal Shore, Director of START GU Oncology Center of Excellence at The START Center for Cancer Research, shared on LinkedIn:
“How enzalutamide affects sex life and how taking a break from treatment affects quality of life: a plain language summary of results from the EMBARK study in people with hormone-sensitive prostate cancer and high-risk biochemical recurrence”
Title: How enzalutamide affects sex life and how taking a break from treatment affects quality of life: a plain language summary of results from the EMBARK study in people with hormone-sensitive prostate cancer and high-risk biochemical recurrence
Authors: Stephen J. Freedland, Ugo De Giorgi, Antti Rannikko, Fred Saad, Martin Gleave, Miguel Ramírez Backhaus, John Mulhall, Bhavik J. Pandya, Jasmina Ivanova, Pavol Kral, James Turnbull, Neal Shore.
Other articles about Enzalutamide on OncoDaily.